Crossmark

Hyperoside Inhibits Doxorubicin-Induced Ferroptosis in Cardiomyocytes via the Nrf2/GPX4 Pathway

Published Online: 2026-01-03

Published Print: 2026-12

Authors

Huang, Mingchun

Li, Yanyan

Li, Yuyan

Xiao, Shuping

Liu, Dan https://orcid.org/0009-0001-6612-5602
Funding

Funding for this research was provided by:

Clinical Research Special Fund of the Wu Jieping Medical Foundation (320.6750.2023-01-22)
License Information

Text and Data Mining valid from 2026-01-03

Version of Record valid from 2026-01-03
More Information

Article History

Received: 1 September 2025

Accepted: 12 November 2025

First Online: 3 January 2026

Declarations

:

: All procedures were approved by the Ethics Committee of The First People's Hospital of Chongqing High-Tech Zone.

: Not applicable.

: The authors report no declarations of interest.

Document is current